INDIA’S COVID-19 TALLY AT 27,02,742, DEATH TOLL GOES UP TO 51,797

• Current Total Cases: 2,702,742

• Total Deaths : 51,797

• Cumulative recoveries : 1,977,779

• Active cases: 673,166

• Top five states that has the maximum number of cases : 

Maharashtra: Cases 604,358, number of deat...

BIOCON'S SYNGENE CLAIMS OF DEVELOPING NEW COVID TECHNOLOGY

Highlights

• Syngene is ready with the technology and will soon send it to the National Institute of Biologicals (NIB) in order to get an approval

• According to executive chairperson Kiran Mazumdar-Shaw, the cost of a test will not exceed Rs 250

• Bio...

Biocon's future focus on making processes robust and GMP compliance

As the chair at the helm of Biocon changes face, there is a new zeal to increase the efforts in making the processes more robust and to make them free from excessive human interference. The company is embarking on a digital journey from the quality control and process control point of view, which...

Biocon, Mylan launch hormone biosimilar in Australia

Biotechnology major Biocon, and company Mylan N V  announced the launch of their hormone biosimilar for the treatment of the polygenic disorder, in Australia.

“We are extraordinarily excited to alter reasonable access to Semglee, a high-quality biosimilar hormone glargine, co...